Work

A phase II study of cabazitaxel in patients with urothelial carcinoma who have disease progression following platinum-based chemotherapy.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.e15519

Authors: Jean H. Hoffman-Censits, David J. Vaughn, Jianqing Lin, Stephen Michael Keefe, Naomi B. Haas, William Kevin Kelly, Terry Hyslop, Monica McGuire, Janelle Robinson, Kattie Khadar, Swati Nanda, Brooke Kennedy, Andrea Borghese Apolo

Institutions: Thomas Jefferson University, Sidney Kimmel Cancer Center, Abramson Cancer Center, University of Pennsylvania, Duke University, Duke Cancer Institute, National Institutes of Health, National Cancer Institute

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2523626178

Cites:

Cited by: 6

Related to: 10